Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA01 - Molecular Subtypes and Prognostic Factors for SCLC and Neuroendocrine Tumors
- 10:45 - 11:45
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Fabio Pagni, Ferdinandos Skoulidis
-
+
MA01.04 - Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance
10:52 - 10:57 | Presenter: Zsolt Megyesfalvi
- Abstract
Loading...
-
+
MA04 - Pulmonology, Radiology, and Staging
- 14:30 - 15:30
- 8/07/2022
- Location: Strauss 3
- Not for CME Credit
- Type: Mini Oral
- Track: Pulmonology, Radiology, and Staging
- Moderators:Mir Alireza Hoda, Pieter Postmus
-
+
Session Moderator
15:22 - 15:30 | Presenter: Mir Alireza Hoda
- Abstract
Loading... -
+
Session Moderator
15:22 - 15:30 | Presenter: Pieter Postmus
- Abstract
Loading... -
+
MA04.01 - Session Introduction
14:30 - 14:31 | Presenter: Mir Alireza Hoda
- Abstract
Loading... -
+
MA04.02 - Session Introduction
14:31 - 14:32 | Presenter: Pieter Postmus
- Abstract
Loading... -
+
MA04.03 - Reconsidering T Classification for T3/T4 Non-small Cell Lung Cancer with Additional Nodule(s)
14:32 - 14:37 | Presenter: Fang Wang
- Abstract
Loading... -
+
MA04.04 - The Ground-Glass Component Status Combined with the Clinical T Descriptor Predicts Prognosis and Genomic Alterations in NSCLC
14:37 - 14:42 | Presenter: Yukihiro Yoshida
- Abstract
Loading... -
+
MA04.05 - T3 Defining Features Influence Long Term Survival after Resection of T3N0M0 NSCLC
14:42 - 14:47 | Presenter: Paula A Ugalde Figueroa
- Abstract
Loading... -
+
MA04.06 - Discussant
14:47 - 14:57 | Presenter: Frank Detterbeck
- Abstract
Loading... -
+
MA04.07 - A Controlled Study of Pathological T- staging and Imaging T-staging of NSCLC Based on Artificial Intelligence
14:57 - 15:02 | Presenter: Yuanyong Wang
- Abstract
Loading... -
+
MA04.08 - Navigation Bronchoscopy Mediated Sentinel Lymph Node Procedure: an Explorative Study in Ex-vivo Lung Cancer Specimens
15:02 - 15:07 | Presenter: Desi Karina Maria ter Woerds
- Abstract
Loading... -
+
MA04.09 - The Incidence and Predictors of Unsuspected Brain Metastases in Patients with Stage IA NSCLC
15:07 - 15:12 | Presenter: Camille Anne Mathey-Andrews
- Abstract
Loading... -
+
MA04.10 - Discussant
15:12 - 15:22 | Presenter: Rudolf M Huber
- Abstract
Loading... -
+
MA04.11 - Live Q&A
15:22 - 15:30
- Abstract
Loading...
-
+
ES12 - Surgical Issues in Multimodality Treatments for Early Stage NSCLC
- 15:45 - 16:45
- 8/07/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Early Stage Non-small Cell Lung Cancer - Surgery
- Moderators:Tomaz Stupnik, Mir Alireza Hoda
-
+
Session Moderator
15:45 - 15:46 | Presenter: Tomaz Stupnik
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:46 | Presenter: Mir Alireza Hoda
- Abstract
Loading... -
+
ES12.01 - Session Introduction
15:45 - 15:46 | Presenter: Tomaz Stupnik
- Abstract
Loading... -
+
ES12.02 - Session Introduction
15:46 - 15:47 | Presenter: Mir Alireza Hoda
- Abstract
Loading... -
+
ES12.03 - The Role of Minimally Invasive Surgery in Multimodality Setting
15:47 - 15:59 | Presenter: Alan D. L. Sihoe
- Abstract
Loading... -
+
ES12.04 - Surgical Challenges of Neoadjuvant Immunotherapy
15:59 - 16:11 | Presenter: Valerie Williams Rusch
- Abstract
Loading... -
+
ES12.05 - Assessment of Resectability after Chemotherapy with Immunocheckpoint Inhibitor or Molecular Targeted Therapies
16:11 - 16:23 | Presenter: Giulia Veronesi
- Abstract
Loading... -
+
ES12.06 - Optimum Surgical Staging and Tissue Acquisition for Adjuvant Immunotherapy and Targeted Treatments
16:23 - 16:35 | Presenter: Paula A Ugalde Figueroa
- Abstract
Loading... -
+
ES12.07 - Live Q&A
16:35 - 16:45
- Abstract
Loading...
-
+
EP02.01 - Early Stage Non-small Cell Lung Cancer - Biomarkers
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Biomarkers
-
+
EP02.01-009 - PD-L1 Expression in Biopsies and Surgical Specimens of Lung Cancer: Impact of Biopsy Methods and Neoadjuvant Therapy
Presenter: Mir Alireza Hoda- Abstract
Loading...
-
+
EP05.02 - Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
-
+
EP05.02-007 - Impact Of Fibrinogen Levels and mGPS on Survival of Stage III/N2 NSCLC Patients Treated with Neoadjuvant Therapy and Radical Surgery
Presenter: Katharina Sinn- Abstract
Loading...
-
+
EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
-
+
EP07.01-014 - Mesothelioma-Associated Fibroblasts Enhance Mesothelioma Aggressiveness and Modulate Drug Response
Presenter: Michael Grusch- Abstract
Loading...
-
+
EP07.02 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
-
+
EP07.02-001 - Evaluation of FGF18 as a Contributing Factor in Malignant Pleural Mesothelioma Growth and Its Role as a Potential Biomarker
Presenter: Berta Mosleh- Abstract
Loading...
-
+
EP14.02 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Preclinical/Translational
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Preclinical/Translational
-
+
EP14.02-003 - Clinical Significance of MYC Family Members in Surgically Resected Limited-Stage Small Cell Lung Cancer: A Multicenter Study
Presenter: Christian Lang- Abstract
Loading...
